Cronos Group (CRON) Q4 2025 Earnings, Here’s a Snapshot

Cronos Group Inc. (NASDAQ:CRON) is 1 of the Low Risk Penny Stocks to Buy Now. On February 26, Cronos Group Inc. (NASDAQ:CRON) reported its fiscal Q4 2025 earnings. The institution posted $44.53 cardinal successful quarterly revenue, up 47.1% year-over-year and up of expectations by $5.78 million.

Management attributed gross maturation to beryllium driven by beardown request for its starring brands, the completion of Cronos GrowCo expansion, and accrued publication from planetary markets. Notably, gross nett for the 4th came successful astatine $16.2 million, reflecting an summation of $5.4 cardinal year-over-year. Management noted the accrued profitability to beryllium led by a higher mean selling terms owed to a amended income premix from Israel and different planetary countries.

Looking ahead, Cronos Group Inc. (NASDAQ:CRON) is affirmative astir its acquisition of CanAdelaar, which volition people its introduction into the European market.

Founded successful 2012 and headquartered successful Toronto, Cronos Group Inc. (NASDAQ:CRON) is simply a cannabinoid institution that cultivates, produces, and markets cannabis products globally. It sells a scope of products specified arsenic dried flowers, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures nether its brands specified arsenic Spinach, Lord Jones, and PEACE NATURALS.

While we admit the imaginable of CRON arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 40 Most Popular Stocks Among Hedge Funds Heading Into 2026 and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None. Follow Insider Monkey connected Google News.